The Medical University of Białystok is a medical university founded in 1950 in a historic building from the 18th century, Branicki Palace, which is the most historically important building for the city of Białystok.

During the past decade, Medical University of Bialystok conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical University of Bialystok" #1 sponsor was "Medical University of Bialystok" with 7 trials, followed by "Sucampo Pharma Americas, LLC" with 2 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "Medical University of Warsaw" with 1 trials sponsored and "MetaCure Limited" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University of Bialystok" #1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "City of Białystok" with 1 trials as a collaborator and "Cooperative Weichteilsarkom Study Group" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Medical University of Bialystok" are "Constipation - Functional" (2 trials), "Glaucoma" (2 trials), "Obesity" (2 trials), "Aortic Valve Insufficiency" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Medical University of Bialystok" in a lesser frequency.

Most popular intervention types in "Medical University of Bialystok" are "Drug" (8 trials), "Procedure" (4 trials), "Device" (2 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lubiprostone" (2 trials), "combined glaucoma surgery" (2 trials), "Aldesleukin" (1 trials) and "Alteplase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of Bialystok" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Medical University of Bialystok". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Medical University of Bialystok, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of Bialystok, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Medical University of Bialystok has several departments that took part in Clinical trials: "Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital" - 4 trials, "Ophthalmology Clinic Medical University of Bialystok" - 3 trials, "Klinika Kardiologii z Oddzialem Intensywnego Nadzoru Kardiologicznego, UM w Białymstoku" - 2 trials, "Medical University of Bialystok; Oncology clinic" - 2 trials, "Klinika Endocrinologii Diabetologii I" - 3 trials, "Medical University of Bialystok, Department of Rehabilitation" - 2 trials, "Department of Pediatric Orthopedics and Traumatology Medical University of Bialystok" - 2 trials, "II Department of Nephrology and Hypertension" - 2 trials